Third Harmonic Bio Statistics
Share Statistics
Third Harmonic Bio has 45.13M
shares outstanding. The number of shares has increased by 10.15%
in one year.
| Shares Outstanding | 45.13M |
| Shares Change (YoY) | 10.15% |
| Shares Change (QoQ) | 0.1% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 3 |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 1.67M, so 3.71% of the outstanding
shares have been sold short.
| Short Interest | 1.67M |
| Short % of Shares Out | 3.71% |
| Short % of Float | 6.08% |
| Short Ratio (days to cover) | 3.93 |
Valuation Ratios
The PE ratio is 9.44 and the forward
PE ratio is -5.34.
Third Harmonic Bio's PEG ratio is
-0.04.
| PE Ratio | 9.44 |
| Forward PE | -5.34 |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 1.51 |
| P/FCF Ratio | -12.44 |
| PEG Ratio | -0.04 |
Financial Ratio HistoryEnterprise Valuation
Third Harmonic Bio has an Enterprise Value (EV) of 147.55M.
| EV / Sales | 0 |
| EV / EBITDA | -3.25 |
| EV / EBIT | -4.28 |
| EV / FCF | -4.28 |
Financial Position
The company has a current ratio of 40.87,
with a Debt / Equity ratio of 0.01.
| Current Ratio | 40.87 |
| Quick Ratio | 40.87 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | -0.07 |
| Debt / FCF | -0.09 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 15.95% and Return on Invested Capital is 20.42%.
| Return on Equity | 15.95% |
| Return on Assets | 15.43% |
| Return on Invested Capital | 20.42% |
| Revenue Per Employee | n/a |
| Profits Per Employee | $1,466,741.94 |
| Employee Count | 31 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -62.78% in the
last 52 weeks. The beta is 2.24, so Third Harmonic Bio's
price volatility has been higher than the market average.
| Beta | 2.24 |
| 52-Week Price Change | -62.78% |
| 50-Day Moving Average | 4.43 |
| 200-Day Moving Average | 8.76 |
| Relative Strength Index (RSI) | 75.01 |
| Average Volume (20 Days) | 599,572 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | 58.87M |
| Net Income | 45.47M |
| EBITDA | -45.42M |
| EBIT | n/a |
| Earnings Per Share (EPS) | 1.09 |
Full Income StatementBalance Sheet
The company has 285.06M in cash and 3.21M in
debt, giving a net cash position of 281.86M.
| Cash & Cash Equivalents | 285.06M |
| Total Debt | 3.21M |
| Net Cash | 281.86M |
| Retained Earnings | -159.69M |
| Total Assets | 279.84M |
| Working Capital | 270.89M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -34.5M
and capital expenditures -10K, giving a free cash flow of -34.51M.
| Operating Cash Flow | -34.5M |
| Capital Expenditures | -10K |
| Free Cash Flow | -34.51M |
| FCF Per Share | -0.83 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
